Cabio Biotech (Wuhan) Co., Ltd. (688089.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 8.43

From 52W high−41.30%

Volume1.09M

Market capCNY 1.26B

P/E (TTM)8.8x

P/S (TTM)3.4x

Div yield—

Key dataSep 18, 2026

Open

CNY 8.43

From 52W high

−41.30%

Volume

1.09M

Market cap

CNY 1.26B

ValuationView details →

P/E (Fwd)

43.9x

EV/EBITDA

6.6x

P/E (TTM)

8.8x

RSI (14)

49.7

MomentumView details →

1D Return

+0.67%

YTD Return

—

ValuationView details →

P/E (Fwd)

43.9x

P/E (TTM)

8.8x

EV/EBITDA

6.6x

EV/Sales

3.3x

P/S (TTM)

3.4x

P/B (TTM)

0.8x

ProfitabilityView details →

Gross Margin

43.41%

Net Margin

13.19%

EBITDA Margin

50.80%

ROE (TTM)

3.47%

ROA (TTM)

2.87%

Asset Turnover

0.22x

GrowthView details →

Revenue YoY

−29.66%

EPS YoY

−62.12%

FCF YoY

+381.93%

Revenue CAGR 3Y

+9.12%

EPS CAGR 3Y

+31.29%

EBITDA YoY

—

MomentumView details →

1D Return

+0.67%

YTD Return

—

1Y Return

—

RSI (14)

49.7

vs 50D SMA

−0.93%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.13x

Current Ratio

3.76x

Quick Ratio

2.80x

Div Yield

—

Div Rate

—

Div Growth 1Y

+0.47%

EarningsView details →

EPS (Actual)

−CNY 0.34

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

−CNY 0.08

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

418.18M

Net Income (TTM)

55.16M

Op. CF (TTM)

224.45M

Next earningsOct 26, 2026 →

Latest newsMore news →

No recent news for 688089.SH.

Similar companies

NewAmsterdam Pharma Company N.V.NAMSW Maze Therapeutics, Inc.MAZE Vor Biopharma Inc.VOR MeiraGTx Holdings plcMGTX Replimune Group, Inc.REPL Immatics N.V.IMTX Find similar companies →

Latest newsMore news →

No recent news for 688089.SH.